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Abstract 
A factor capable of deforming erythrocyte membranes, found in the culture supernatants of Bartonella bacilliformis, was purified 
1840-fold using hydrophobic, ion exchange and gel exclusion chromatography. The final fractions contained a single detectable 
polypeptide species, referred to as deformin, having a molecular weight of 67 000 by SDS-PAGE and a native molecular weight of 
130000 by gel exclusion chromatography or velocity sedimentation i a glycerol gradient. Erythrocytes treated with deformin acquire 
trenches, indentations, and invaginations which could be reversed by vanadate, dilauroylphosphatidylcholine (DLPC), or by raising the 
internal Ca 2+ concentrations with the ionophore A23187. Internal vacuoles also form. Erythrocytes treated with trypsin or neuraminidase 
are much more sensitive to deformin than untreated erythrocytes; erythrocytes treated with phospholipase D are less sensitive to deformin. 
This protein may play a role in causing the severe anemia which can result as a consequence of infection by B. bacilliformis. 
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1. Introduction 
Human erythrocytes are well known to serve as hosts 
for malaria and babesia and they also serve as targets for 
the pathogenic bacterial species, B. bacilliformis. The 
route of infection is through the bite of a nocturnal sand 
fly and a single night of unprotected exposure in the 
endemic area, certain valleys of the Andes, mainly in Peru 
but also in Ecuador and C.olombia, is apparently sufficient 
to contract bartonellosis in one of its two manifestations. 
Oroya fever, which is named after the town of Oroya, Peru 
where more than 7000 workers constructing the Central 
Railway between Lima and Oroya died in 1870, is charac- 
terized by a fulminant anemia in which the erythrocytes 
Abbreviations: BSA, bovine serum albumin; BHI, brain heart infu- 
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become parasitized by B. bacilliformis. Nearly 100% of 
the erythrocytes are affected and the patient may die of an 
anemia of rapid onset with red cell counts as low as 
500000/mm 3. Survivors of the acute anemia of Oroya 
fever, as well as infected persons who did not display a 
noticeable hematic phase, may develop verruga peruana in 
which endothelial cells infected by the bacteria give rise to 
verrugas, highly vascular cutaneous miliary or nodular 
eruptions. Verruga peruana is not a fatal disease and the 
development of verrugas in Oroya fever was traditionally 
taken as an indication that the patient would recover. The 
mortality rate of Oroya fever in the pre-antibiotic era was 
very high, about 40%, but not high enough to save the 
Incas from Pizarro and his soldiers, many of whom died 
from a plague-like disease reminiscent of small-pox, and 
who were reported by Garcillasco de la Vega (1539?-1616) 
to have developed fever and mysterious and loathsome 
skin warts which were very prone to bleeding [1], almost 
certainly verrugas. For an interesting historical review, see 
Strong [2]. 
The anemia of bartonellosis is the result of splenic 
removal of abnormal erythrocytes. Incubation in vitro of 
174 Y.-H. Xu et al. / Biochimica et Biophysica Acta 1234 (1995) 173-183 
B. bacilliformis with human erythrocytes resulted in 
marked changes in the surface of the erythrocytes, includ- 
ing trenches, indentations and invaginations, as well as 
binding of individual bacteria nd clumps of bacteria to the 
erythrocytes [3]. Bacteria were often seen lying within 
deep indentations of the erythrocyte membrane. However, 
erythrocytes were routinely and frequently seen which did 
not have bacteria bound to their surfaces, but which dis- 
played equivalent morphological changes. A factor, termed 
deformation factor, was previously found in the super- 
natant of B. bacilliformis cultures [4]. This factor was 
capable of producing all the morphological changes that 
resulted when living bacteria were incubated with the cells. 
Deformation factor was shown to be stable on storage at 
4 ° C, but could be inactivated by proteinases or brief 
heating to 70 ° C-80°C and was retained by membranes 
with a 30 000 molecular weight cutoff. This activity could 
be an agent partially responsible in Oroya fever for the 
changes in erythrocyte morphology which lead to ery- 
throphagocytosis and anemia. 
Deformation factor may play a role in permitting the 
bacteria to gain entry to erythrocytes through a process 
similar to endocytosis or phagocytosis. B. bacilliformis 
may provide a convenient model to study the process by 
which infectious agents gain entry into cells. Since 
erythrocytes are not phagocytic and have little or no 
residual capability for endocytosis after maturation, B. 
bacilliformis must actively gain entry into the cells, rather 
than entering passively by phagocytosis or cell controlled 
endocytosis. 
Here we report the purification of deforming factor 
1840-fold and the presumptive identification of the de- 
forming activity with a dimer of a 67 000 Da polypeptide, 
termed deformin. 
2. Materials and methods 
2.1. Bacteria and growth conditions 
General procedures used for growing B. bacilliformis 
are described in [3,4]. Cultures used for the isolation of 
deformin were grown by one of two procedures. In the 
first, an inoculum of 0.6 ml unwashed bacteria grown in 
brain heart infusion (BHI) medium was added to 8 ml 
sterile phosphate-buffered saline (PBS, 8 mM Na 2 HPO4, 1 
mM KH2PO4, 3 mM KC1, 117 mM NaC1, pH 7.4) over 
BCYE agar (Difco) in a 100 X 15 mm petri dish. The 
cultures were incubated at 28°C for 3 days. The liquid 
overlay was centrifuged at 15 000 rpm for 10 min and the 
supernatant was filtered through a 0.2 /zm Acrodisk filter. 
Typically the supernatant contained 200-600 U/ml  of 
deforming activity. An alternative procedure was used to 
minimize the amount of added protein to the growth 
medium. B. bacilliformis was centrifuged twice to remove 
protein from the BHI medium and resuspended in PBS. 0.6 
ml was added to BCYE agar (Difco) overlain with 8 ml 
sterile PBS containing 0.5% BHI, 1% tryptone, and 0.004% 
hemin. The bacteria grew less well in this medium and the 
supernatant contained about 50-100 U/ml  of deforming 
activity. 
2.2. Enzyme and phospholipid assays 
Sphingomyelin (40 /xg) was dissolved in chloroform 
and the solvent removed by a stream of nitrogen. 1 ml of 
detergent buffer (0.5% Triton X-100, 1 mM Mg 2÷) in PBS 
was added and samples vortexed until the solution cleared 
[5]. This was incubated for 1 h at 37 ° C with added enzyme 
(10 /xl) Staphylococcus aureus sphingomyelinase C 
(Sigma) or purified deformation factor (1000 units/ml) 
and extracted with ch lo ro form/methano l /HC1 
(100:50:0.5). Sphingomyelinase activity was assayed using 
thin-layer chromatography [6]. 
Erythrocytes were treated with 5 units of purified de- 
formin and their lipids were extracted according to Turner 
[7]. Lipid standard (Avian) and samples of the lipid ex- 
tracts were spotted onto HPTLC-alufolien Kiesel Gel 60 
plates (E. Merck, Darmstadt, Germany) and the plates 
were developed in a solvent system composed of chloro- 
form/methanol/ammonium hydroxide (65:35:8) and visu- 
alized with iodine vapors. The phospholipid was quantita- 
tively determined after digestion of the spots with 70% 
perchloric acid by phosphorous analysis using the method 
of Lanzetta [8]. 
2.3. DLPC vesicles 
A suspension of 10 mM DLPC in PBS was sonicated 
under N 2 until clear. Sonicated vesicles were incubated 
with deformed trypsinized erythrocytes for various times 
and aliquots of the cells were then fixed in 0.5% glu- 
taraldehyde for 10 min at room temperature for light 
microscopic analysis [9]. 
2.4. Assay of deforming activity 
One deforming unit was defined as the amount of 
deformin eeded to deform 50% of the trypsinized erythro- 
cytes under standard conditions. Specific activities were 
calculated using protein concentrations determined using 
the micro BCA assay kit (Bio-Rad) and BSA as standard. 
Erythrocytes were trypsinized by incubation at 50% hemat- 
ocrit for 1 h with trypsin (1 mg/ml),  or in some cases 
were treated with neuraminidase (0.5 units/ml). The ery- 
throcytes were washed in PBSGI (PBS containing 10 mM 
glucose, 5 mM inosine) and resuspended in the same 
medium at 4 ° C at 50% hematocrit. 20 /zl of trypsinized 
erythrocytes (final concentration 108 cells/ml) were added 
to 0.6 ml of binding medium (10 mM phosphate buffer, 
pH 7.4, 0.7% NaC1, 10 mM glucose, 5 mM inosine, and 
0.5% human serum albumin) (Sigma). Human serum albu- 
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min was included in the binding medium to prevent loss of 
deformation activity at low concentrations. Aliquots of 
culture filtrate or fractions from column chromatography 
were then added. After incubation at 37 ° C, generally for 2 
h, 10 /zl of the red cell suspension was fixed for 10 min 
with an equal volume of 1% glutaraldehyde in PBS. At 
least 200-300 erythrocyte.s were examined using a Zeiss 
microscope quipped with phase optics; those scored as 
positive had prominent invaginations, pits or trenches. 
2.5. Electron microscopy 
3 /xl of packed erythrocytes were resuspended in 1% 
glutaraldehyde for 20 min at room temperature, washed 
with distilled water three times and resuspended in 1 ml of 
distilled water. 2 /zl of the cell suspension were air dried 
on a ~glass coverslip and samples were sputter-coated with 
150 A gold-palladium about 1 min before viewing with the 
scanning electron microscope. 
For transmission electron microscopy, after glutaralde- 
hyde fixation, the erythrocytes were fixed in 1% OsO 4 in 
PBS buffer for 30 min and then serially dehydrated in 
acetone-water. Samples were embedded in Epon and thin 
sections were stained with lead citrate and uranyl acetate. 
Thin sections were observed by transmission electron mi- 
croscopy using a Zeiss 10C electron microscope. 
and NaCI from 0.1 M to 0.5 M. Deforming activity was 
found to be eluted between 0.3 M and 0.4 M NaC1. The 
active fractions were pooled and concentrated with cen- 
triprep (Aminco, 30 000 molecular weight cut off). The 
concentrate was loaded onto an FPLC Superose 6 column 
equilibrated with 50 mM Tris, pH 8.0, 0.4% cholate and 
eluted at a flow rate of 0.5 ml/min. Fractions were 
assayed using 5-10 /xl aliquots added to 0.6 ml of assay. 
Final concentrations of cholate were below 0.01%, which 
did not cause any deformation. 
2.8. Molecular weight determination 
Polypeptides were detected by SDS-PAGE (10%) visu- 
alized with Daichi silver stain (Daichi Pure Chemicals) or 
Coomassie brilliant blue, and their molecular weights de- 
termined by comparison with standard proteins. Native 
molecular weights were obtained by comparison with stan- 
dard proteins on Superose 6 gel filtration and by glycerol 
gradient centrifugation. 0 5 ml of filtrate was loaded on the 
top of a 20%-5% glycerol gradient and centrifuged for 16 
h at 40000 rpm at 5°C in an SW50.1 rotor. The gradient 
was fractionated and assayed for deforming activity and 
the locations of standard marker proteins was determined 
on Coomassie brilliant blue SDS-PAGE. 
2.6. Fluorescence microscopy 3. Results 
Trypsinized erythrocytes were incubated in isotonic 
buffer containing 1% FITC-BSA for 2 h at 37 ° C with or 
without deformation factor. The erythrocytes were washed 
with PBS and fixed with 1% glutaraldehyde. To reduce 
fading, the sample was mounted in glycerol (pH 8.0) 
containing antifade (p-phenylenediamine) for viewing by 
epifluorescence microscopy using the 100 X oil immersion 
objective [10]. 
2.7. Column chromatography 
Filtrate (360 ml, 200--400 U/ml  deforming activity) 
was centrifuged at 35 000 rpm for 1 h and the supernatant 
was applied to a 1.5 cm ;< 6 cm phenyl-Sepharose CL-4B 
column (Pharmacia), pre-equilibrated with 5 bed volumes 
of PBS buffer. The column was washed with PBS and then 
with 10 mM Tris buffer, pH 9.0 until the absorbance of the 
eluate returned to the base line. Most the added protein but 
none of the added deforming activity was recovered in the 
column wash. Deforming activity was eluted with 10 mM 
Tris, pH 9.0, 2% cholate at a flow rate of 15 ml/h.  
The active fractions were pooled and loaded onto a 
1.5 × 3 cm) DEAE-Sephacel column (Pharmacia) pre- 
equilibrated with 10 mM Tris buffer, pH 8.0 and washed 
with 10 mM Tris, pH 8.0, followed by 10 mM Tris, pH 
8.0, 0.1 M NaC1, 1% cho]late. The column was then eluted 
with a linear gradient of 10 mM Tris, pH 8.0, 1% cholate, 
3.1. Semi-quantitative assay for deformation activity 
Incubation of erythrocytes with bacteria-free filtrates of 
the culture medium used to grow B. bacilliformis resulted 
in extensive deformation of the erythrocytes, as shown in 
Fig. 1B-D. Based on this property, a standard assay for 
deformation activity was developed, which permitted yields 
to be quantitated and the location of deforming activity to 
be determined in the various fractions. Several potential 
problems needed to be considered before this biological 
assay could be used to monitor deformation activity during 
purification. First, individual erythrocytes are deformed to 
various extents. We chose to consider only two states for 
the cells, normal and deformed, without consideration of 
the extent of deformation, because we found that as in- 
creasing amounts of filtrate were added, the clearest conse- 
quence was a decrease in the fraction of undeformed cells 
and this decrease was simple to quantitate. Second, several 
different morphological changes are observed, including 
pits, trenches, invaginations and depressions, as can be 
seen in Fig. 1. We did not observe any obvious transition 
from one type of morphology to another as increased 
amounts of filtrate were added, and so we regarded all 
forms of deformed morphology as equivalent. Third, ap- 
parently undeformed erythrocytes coexist with extensively 
deformed erythrocytes, uggesting that not all erythrocytes 
are equally sensitive to deforming factor. The sensitivity of 
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Fig. 1. Scanning electron mncrograph of erythrocytes. (A) Trypsinized 
normal erythrocytes. (B-D) Trypsinized erythrocytes incubated with 
filtrate for 2 h at 37 ° C. (E-F) Trypsinized erythrocytes incubated with 
purified deforming factor for 2 h at 37 ° C. 
the erythrocytes can be greatly increased by preincubation 
of the erythrocytes with trypsin or, to a lesser extent, with 
neuraminidase. Preincubation of the erythrocytes with 500 
~g/ml  phospholipase D for 30 min at 37°C converted 
part of the phosphatidylcholine to phosphatidic acid and 
decreased the fraction of cells deformed by 5 units of 
deforming factor from 80% to 20% (data not shown). 
Erythrocytes were routinely trypsinized, since preincuba- 
tion with trypsin seemed to yield a more homogenous 
population of erythrocytes and, in any case, made the 
assay more sensitive. 
Finally, conversion of the normal morphology to the 
deformed was not related in a simple or linear way to 
experimental variables uch as time or filtrate concentra- 
tion. After incubation of trypsinized erythrocytes with 
filtrate, the appearance of deformed cells occurred only 
after a lag time of a few minutes to more than an hour. 
Similar lag periods were observed with purified deformin, 
as discussed below. The length of the lag time was depen- 
dent on the concentration of filtrate added to the assay 
system. With increasing times of incubation, the fraction 
of erythrocytes seen to be deformed increased, up to some 
maximal value which was dependent on the amount of 
filtrate added. At high concentrations of filtrate, nearly 
100% of the cells became deformed, indicating that there 
was not a fraction of erythrocytes resistant to the action of 
deformation factor. At low concentrations of deforming 
factor, several hours of incubation was needed for the 
extent of deformation to become maximal and even then 
only a minority of the erythrocytes became deformed. 
These considerations lead us to routinely employ an incu- 
bation time of 2 h as the standard. Prolonged incubation 
increased the sensitivity of the assay and eliminated the lag 
time as a significant consideration. The reproducibility of 
the assay and the purification described below was very 
good; all the experiments reported here were generally 
repeated at least three times with equivalent results. 
Addition of increasing amounts of filtrate caused higher 
percentages of erythrocytes to be deformed. However, the 
percent deformed was not related to the amount of filtrate 
added in a simple linear way; instead a sigmoidal dose-re- 
sponse curve was observed. We did not consider the assay 
to be very reliable when either a small fraction or a large 
fraction of the erythrocytes were deformed and so we took 
50% deformation after 2 h of incubation to be the desired 
end point of the assay. During purification, each fraction 
too t A 100.. 
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Fig. 2. Sensitivity of erythrocytes to deformation after trypsin or neuraminidase tr atment. (A) A 50% erythrocyte suspension was treated with trypsin for 0 
(11), 1 (O), 10 (O), 30 (©), and 60 (* )  min. (B) Erythrocytes were treated with neuraminidase (0.5 U/ml)  for 0 (11), 1 (D), 10 (D), and 60 ('Jr) min. 
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needed to be assayed at several different concentrations in 
order to find an amount of activity which resulted in 
approximately 50% deformation. We defined 1 unit of 
deformation activity to be the amount which caused 50% 
deformation under the standard conditions using trypsinized 
erythrocytes. Fig. 2 shows the percent deformation plotted 
against he amount of filtrate added for erythrocytes incu- 
bated for various times with trypsin (Fig. 2A) or neu- 
raminidase (Fig. 2B). The sensitivity of the assay is in- 
creased about 100-fold by trypsin treatment and about 
25-fold by neuraminidase treatment, using 50% deforma- 
tion as the assay standard. For example, in Fig. 2A, about 
100 /zl of filtrate is required to reach 50% deformation of 
untrypsinized cells, whereas fully trypsinized cells are 50% 
deformed by about 1 /zl of filtrate. The response of the 
trypsin-treated rythrocytes i  more homogenous than that 
for untreated erythrocytes or neuraminidase-treated 
erythrocytes, in the sense that only a small increase in 
filtrate added is needed to convert he trypsinized erythro- 
cytes from mostly undeformed to mostly deformed. 
3.2. Purification of deformin 
Purification of deform~in was complicated by the fact 
that the culture medium contained significant amounts of 
human serum and erythrocyte lysate. Much of the purifica- 
tion needed could have been accomplished simply by not 
adding these complex mixtures of proteins to the growth 
medium. A further complication was that human serum 
contains an inhibitor of deforming activity. We devoted 
considerable time to develop a satisfactory growth medium 
lacking added proteins, but we were unsuccessful. Al- 
though we were able to grow B. bacilliformis in protein 
free medium, the bacteria grew much more slowly and the 
deforming activity of the filtrate was greatly diminished. 
Deforming factor proved to be a relatively stable pro- 
tein. Not only did it remain active in the supernatant over 
several days of incubation while the bacteria were grow- 
ing, but also the crude filtrate could be stored for more 
than 3 months at -20  ° C with little or no loss of activity. 
The culture medium was centrifuged to remove bacteria 
and filtered through a 0.2 /xm Acrodisk filter, centrifuged 
again at 100000 x g for 1 h, and loaded onto a phenyl- 
Sepharose CL-4B column. After washing the column, 
bound protein was eluted with 10 mM Tris buffer, pH 9.0 
and 2% cholate. Essentially no deforming activity was 
present in the flow through, nor was any activity eluted 
from the column in low ionic strength buffer (10 mM Tris, 
pH 9.0). The fact that the deforming factor bound strongly 
to this column and required cholate to be eluted indicates 
that deformin is a very hydrophobic protein. 
The deforming factor was further purified using 
DEAE-Sephacel. In the initial experiments, deforming fac- 
tor was eluted with 0.15 M NaC1, along with many other 
proteins. Purification was improved markedly by equili- 
brating the column with buffer containing 1% cholate and 
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Fig. 3. Superose 6 chromatography rofile. The symmetric first protein 
peak, which has an apparent molecular weight of 130000, contains all the 
deforming activity (specific activity 227 U//zg). Only a 67000 molecu- 
lar weight protein is seen by silver stain (inset). 
washing the column with 10 mM Tris (pH 8.0), 0.1 M 
NaC1, 1% cholate. Under these conditions most of the 
impurities eluted from the column, but deforming factor 
remained bound and was subsequently eluted with 0.35 M 
NaCI. 
After concentration, the deforming factor was applied to 
an FPLC Superose 6 column equilibrated with 50 mM Tris 
buffer (pH 8.0), 0.4% cholate. Cholate was necessary to 
prevent irreversible adsorption of the protein to the col- 
umn. The deformation activity co-eluted with the first 
symmetric protein peak at a position corresponding to a 
molecular weight of about 130 000 (Fig. 3). The fractions 
corresponding to the deforming activity contained only one 
detectable polypeptide with an apparent molecular weight 
of 67000 on SDS-PAGE using silver staining. Glycerol 
gradient sedimentation was used to provide a second esti- 
mate of the native molecular weight, using fumarase, lactic 
dehydrogenase, BSA, and carbonic anhydrase as known 
molecular weight standards. The deforming activity sedi- 
mented slightly slower than lactic dehydrogenase (140000 
molecular weight), with an S20,w of 6.5 and an apparent 
molecular weight of about 130 000 (Fig. 4). 
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Fig. 4. Sedimentation f deforming factor in a glycerol density gradient. 
The position of deforming factor relative to fumarase (9.1S, 192 kDa), 
lactate dehydrogenase (7.0S, 140 kDa), BSA (4.2S, 61 kDa), and car- 
bonic anhydrase (2.9S, 31 kDa) is indicated. 
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Fig. 5. Heat inactivation of deforming factor. The protein was heated for 
5 min at various temperatures and the residual activity determined. The 
results given are the average of three experiments. 
The results of this purification process are summarized 
in Table 1. Similar results were obtained in five separate 
purifications. It can be seen that each step resulted in 
considerable purification, but also considerable loss in 
recovered activity. Deformation factor prepared by two 
separate purifications was sent to two different protein 
sequencing laboratories, but in neither case could an N- 
terminal sequence be obtained, either because the amount 
was too small or because the N-terminus was blocked. 
3.3. Properties of purified deformation factor 
In all respects tested, the properties of the purified 
deformation factor were equivalent to those observed with 
the filtrate of the culture supernatant. This indicates that a 
second factor is not present in the culture filtrate and that 
the activity of deforming factor is not altered by purifica- 
tion. The morphology of erythrocytes incubated with the 
purified deformation factor, as shown in Fig. 1E and IF 
are very similar to erythrocytes incubated with the culture 
supernatant (Fig. 1B-D). Fig. 5 shows that the purified 
deformation factor was completely heat inactivated by 
incubation for 5 min at temperatures above 80 ° C, as was 
found for the deforming activity in the culture filtrate [4] 
and is partially inactivated by incubation for 5 min at 
temperatures between 60 ° C-70 ° C. 
The kinetics of deformation of trypsinized erythrocytes 
is shown in Fig. 6. There is a lag period, the length of 
which decreases with increasing concentration of deform- 
ing factor, before obviously deformed erythrocytes were 
seen. At higher concentrations of deforming factor, 100% 
of the erythrocytes could be deformed, but when lower 
concentrations of deforming factor were used, the percent- 
age of deformed cells eventually reached a plateau. The 
overall shape of the time course was sigmoid at each of the 
concentrations examined. 
The concentration dependence of deformation for both 
purified deformation factor and filtrate is shown in Fig. 7. 
In both cases, there is a concentration range below which 
only a small percentage of cells are deformed and above 
which essentially all the cells are deformed. This concen- 
tration range is rather narrow when trypsinized erythro- 
cytes are used, and the plot of % deformation versus added 
deforming activity is sigmoidal. In an experiment where 
Table 1 
Purification of DF protein from Bartonella-free culture filtrate 
Purification Volume Activity Protein Total activity Specific activity Purification 
step (ml) (U/ml) (/xg/mi) (kUnits) (kUnits/mg) (x-fold) 
Culture filtrate 360 200 4000 72 0.075 1 
Phenyl-Sepharose 24 750 125 18 6 80 
DEAE-Sephacel 15 200 4 3 50 666 
Gel filtration 15 100 0.44 1.5 227 1840 
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Fig. 6. Kinetics of deformation f trypsinized erythrocytes bypurified eformin. Concentrations used are 0.25 (•),  0.50 (A), 1.25 ([]), 2.5 (•),  5 (O), 
and 10 (0)  units. 
the concentration of deformation factor was constant (using 
in this experiment the filtrate) and the number of erythro- 
cytes varied, the percentage of erythrocytes deformed was 
nearly 100% at low co~Lcentrations of erythrocytes and 
decreased with increasing concentrations of erythrocytes 
(Fig. 8B). 
Erythrocytes treated with S. aureus sphingomyelinase C 
or Corynebacterium pseudotuberculosis phingomyelin 
phospholipase D develop a morphology similar to that 
observed with deformation factor [11,12]. When trypsinized 
erythrocytes were incubated with 0.4 /xg of S. aureus 
sphingomyelinase C (Sigma), about 95% of the cells were 
deformed in 1 mM Mg :~÷, but less than 5% in 1 mM 
EDTA after 2 h at 37 ° C. With 4 units of deformation 
factor, about 95% of the erythrocytes were deformed both 
in 1 mM Mg e+ and in 1 mM EDTA. More than 95% of 
the erythrocytes treated with sphingomyelinase C were 
sensitive to cold lysis (5 rain at 4 ° C) whereas less than 5% 
of the erythrocyte treated with deformin lysed. Phospho- 
lipid was extracted from the treated erythrocyte mem- 
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Purified DF jul of filtrate 
Fig. 7. Concentration dependence of deformation of trypsiuized erytbro- 
cytes by purified eformin (A) c r filtrate (B). 20/zl of erythrocytes (50% 
hematocrit) n 0.6 ml of binding medium was mixed with the indicated 
amounts of filtrate or deforming factor and incubated 2 h at 37 ° C. In B, 
a control filtrate (O) form uninoculated growth medium did not deform 
erythrocytes. The results given are the average of three experiments. 
branes and analyzed by thin-layer chromatography. There 
was no change in the amounts of phosphatidylcholine or 
sphingomyelin seen by thin-layer chromatography or in the 
number or location of spots on the chromatogram for cells 
treated with deformin, whereas with cells treated with S. 
aureus sphingomyelinase C about 1 /3  of the sphingo- 
myelin was degraded (data not shown). 
Direct assay using thin-layer chromatography of 4 units 
of deformin for sphingomyelin or phosphatidylcholine did 
not reveal any phospholipase activity. 
3.4. Depletion of  activity 
Assuming that deforming factor might bind to erythro- 
cytes, erythrocytes were incubated with deforming factor 
and then removed by sedimentation to determine how 
80 
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Number of incubation IIRB(~ ¢ ~  (1{107) 
Fig. 8. Depletion of deforming activity by trypsinized erythrocytes. (A) 
After incubation for 2 h with filtrate erythrocytes were removed by 
centrifugation at 2000 × g for 5 min; the supernatant was then incubated 
with the same volume of fresh erythrocytes for 2 h and again the 
erythrocytes were removed by centrifugation. 1) no erythrocytes added 
(O), 10 p.1 of erythrocytes (O), 40 /~1 of erythrocytes ( I ) .  (B) The 
percent deformation bserved with various concentrations of trypsinized 
erythrocytes. 
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C D 
F 
Fig. 9. FITC-BSA was added to erythrocytes in the absence (A,C) or presence (B,D) of deforming factor. Fluorescence microscopy (A,B) showed the 
presence of small fluorescent vacuoles after addition of deforming factor (B). FITC-BSA by itself deformed some of the ceils (C). 
much deforming activity remained in the supernatant. If 
little deforming activity remained in the supernatant when 
erythrocytes were incubated with an amount of deforming 
factor capable of deforming a much larger number of 
erythrocytes, we perhaps could conclude that more deform- 
ing factor can bind to erythrocytes than the minimum 
needed to deform the cells, and might be able to estimate 
the number of binding sites per cell. Fig. 8A shows that 
when 10 /zl of erythrocytes was incubated for 2 h with 
filtrate and removed by centrifugation for 5 min, substan- 
tial deforming activity remained in the supernatant and the 
incubation could be repeated again with flesh erythrocytes 
with little depletion of the deforming activity remaining in 
the supernatant. On the other hand, when the same experi- 
ment was done with four times as many erythrocytes, only 
about 50% of the original deforming activity remained 
after the first incubation and none after the second. This 
experiment demonstrates that deforming activity is lost 
from the supematant after interaction with cells, either 
because it binds to the cells or because it is somehow used 
up in the process, and also that the activity is lost in 
proportion to the number of cells added. 
A B 
Fig. 10. Transmission electron microscopy of deformed red cells. Trypsinized erythrocytes were incubated in isotonic buffer containing 1% FITC-BSA 
without deformation factor (A) or with deformation factor (B) for 2 h at 37 ° C. Numerous mall vacuoles are seen in the erythrocytes treated with 
deformation factor (B). 
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3.5. Internalization 
Deformation factor aloJae, in the absence of bacteria or 
other added substances, is capable of causing the formation 
of internal vesicles in eryl:hrocytes. When FITC-BSA was 
present in the medium, some of it became entrapped in 
intracellular vesicles and could not be washed away (Fig. 
9). The entrapped fluorescence appeared to be contained in 
small fluorescent clusters anderneath t e membrane. In the 
electron microscope, the vacuoles were of variable size 
and most of them appeared to be close to the membrane 
(Fig. 10). FITC-BSA alone deformed some of the cells 
(Fig. 9C) but none was internalized (Fig. 9A). This experi- 
ment demonstrated that deforming factor not only alters 
the surface topography of the erythrocyte membrane, but 
also is capable of causing internalization of extracellular 
fluid by the creation of closed internal vesicles (for a 
review of entrapment in erythrocytes, ee Schrier [13]). 
100" 
~8o-  
c 
~60" 
0 
~40.  
0 
20" 
~ 0--.0 
- I I i  f I i 
o.1 11o 1'o 
vanadate (uM) 
Fig. 12. Inhibition of deformation byvanadate. Trypsinized erythrocytes 
were incubated with various concentrations of vanadate and with 3 units 
of deforming factor with (Q) or without (O) deforming factor. Concen- 
trations of 1 /xM or above inhibited eformation. 
3.6. Reversibility of  deformation 
Deformed cells incubaled overnight were found to have 
spontaneously reverted to the biconcave shape. Several 
chemicals could revert tile deformed cells very quickly. 
Vanadate (10-300 tzM), raising the intracellular Ca 2÷ 
concentration using A23187 [14] (Fig. l lA -C) ,  or acquisi- 
tion of DLPC from lipid vesicles by the outer leaflet of 
erythrocyte membranes (Fig. l lD -F )  quickly reverted the 
deformed red cells to biconcave discs, within 30 s after 
addition of A23187 or 1 min using DLPC vesicles. Further 
incubation with these agents caused the formation of 
echinocytes. Low concentrations of vanadate (1-10 txM) 
which by themselves did not cause any observable mor- 
phological change and were too low to reverse deforma- 
tion, nevertheless were capable of preventing deformation 
by low concentrations of deformation factor (3 U) (Fig. 
12). 
4. Discussion 
Fig. 11. Deformed erythrocytes were incubated with 5 IxM of ionophore 
A23187 in 0.1 mM Ca 2÷ for 20 s (A), 1 min (B), or 5 min (C) before 
fixation in 0.5% glutaraldehyde; formed erythrocytes were incubated 
with 2.5/xl of 10 mM DLPC vesicles for 0 min (D), 1.5 min (E) or 3 min 
(F) before fixation. 
We report here the purification of deformation factor 
activity from the bacteria-free supernatants of cultures of 
B. bacilliformis. The deformation activity was purified 
about 1840-fold, using hydrophobic, ion exchange and gel 
exclusion chromatography. Deformation activity sediments 
in glycerol gradient centrifugation and elutes from Super- 
ose 6 with an apparent molecular weight of 130 000. The 
only polypeptide species which we could detect in these 
fractions migrated on SDS-PAGE with a molecular weight 
of 67 000, suggesting that deformin is a dimer. 
The supernatant from cultures of B. bacilliformis con- 
tains significant amounts of many of the outer membrane 
proteins of B. bacilliformis (Arevalo, J., unpublished ob- 
servations). These appear to be present as membrane frag- 
ments or vesicles. In view of this, it is not clear whether 
deformation factor is secreted from the bacteria as an 
extracellular protein or, alternately, is a component of the 
bacterial outer membrane and is present in the supernatant 
along with other membrane proteins as the result of some 
vesiculation process. A protein of about 67 000 molecular 
weight can be faintly detected in outer membrane prepara- 
tions. One argument that the activity might be surface-as- 
sociated is that the serum contains an inhibitor of deform- 
ing factor, so that deforming factor on the bacterial surface 
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in close proximity to the erythrocyte membrane would be 
expected to be more active and less inhibitable by serum. 
Despite considerable effort we were unable to characterize 
the nature of the inhibitory activity in serum. 
Although substantial purification of deformin was 
achieved by this purification scheme, the overall yield was 
only about 2%. We believe the low yield of purified 
protein is the result of its hydrophobic properties. Cholate 
is necessary to prevent non-specific loss of deformin dur- 
ing purification and in the absence of cholate, losses are 
very high, up to 100%. It was not possible to obtain an 
N-terminal amino acid sequence on the 67 000 molecular 
weight polypeptide, either because the N-terminus is 
blocked or, more likely, because it was not possible to 
purify adequate amounts of the protein for sequencing. 
Since we were unable to obtain an amino acid sequence, it
was not possible to isolate a clone of the gene for nu- 
cleotide sequencing using the amino acid sequence to 
configure a DNA probe, or to compare apartial amino acid 
sequence with the protein database. Without some addi- 
tional evidence that the 67 000 protein is related to other 
membrane active proteins, the identification of this 
polypeptide with the deforming activity rests mainly on 
our inability to detect some other protein in the fractions 
containing deforming activity. 
We considered the possibility that deformin might be an 
enzyme catalyzing a reaction involving a component of the 
membrane, but we could obtain no direct evidence for this 
possibility. No obvious changes were seen in the phospho- 
lipid components of membranes of erythrocytes treated 
with deforming factor. Deformin did not appear to have 
sphingomyelinase or other phospholipase activities when 
assayed irectly. Whether deformin is an enzyme or acts in 
some other way on a membrane component, it might bind 
to erythrocyte membranes, possibly to a specific receptor 
in the membrane. The heterogeneous response of the red 
cells to deformin, particularly the untrypsinized cells, sug- 
gest that the red cell population itself is heterogeneous, 
possibly due to red cell age. However, this is a compli- 
cated question since storage of the red cells reduces their 
sensitivity and since red cells freshly trypsinized are more 
sensitive than stored trypsinized red cells. It is interesting 
that incubation of a relatively large number of erythrocytes 
with deformin followed by centrifugation of the erythro- 
cytes leaves the supematant deficient or devoid of deform- 
ing activity. However, incubation and centrifugation of 
one-fourth as many erythrocytes under similar conditions 
leaves most of the deforming activity in the supernatant. 
This suggests that there may be a relatively limited number 
of targets per erythrocyte for deformin. We estimate that in 
the standard assay, only about 500 molecules of deformin 
per erythrocyte are present and perhaps 80% of these 
remain in the supernatant when the cells are removed by 
centrifugation. 
Several agents - increased intracellular Ca 2÷, DLPC 
and vanadate - all reversed the action of deformin. The 
action of vanadate is believed to inhibit a Mg2+-ATPase 
which functions as an aminophospholipid translocase 
[15,16]. DLPC is directly transferred to the erythrocyte 
membrane [9]. The ability of these compounds to reverse 
deformation suggests that deformin may act to alter the 
lipid composition or asymmetry of the membrane, accord- 
ing to the hypothesis of Sheetz and Singer [17,18]. For a 
review, see Backman [19]. 
When increasing concentrations of deformin are added 
to trypsinized erythrocytes, the percentage of deformed 
cells changes abruptly from near zero to nearly 100% with 
an S-shaped curve. It is not possible to infer anything 
about the state of association of deformin however, since 
the width of this transition, as well as the sensitivity of the 
erythrocytes to deformation, is very much determined by 
how completely the erythrocytes have been trypsinized. It 
is clear that 100% of the erythrocytes are sensitive to 
deformation if enough deformin is added, but that much 
more deformin is required for cells that are not trypsinized 
or only lightly trypsinized than for cells extensively 
trypsinized. Similarly it is difficult to interpret he ob- 
served time course, with its lag period and apparent satura- 
tion, since this may reflect more the variable resistance of 
a heterogeneous population of erythrocytes than any mech- 
anistic considerations. 
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